CRP and myocardial infarction: Furthermore, PCLeB had been associated with a lesser increase in C-reactive protein (CRP) in patients with STEMI, compared to the matched control, in our matched case–control study [46], which may contribute to good outcomes in patients with STEMI since excessive early inflammation after myocardial infarction has been associated with adverse left ventricular remodeling [54, 55] and poor outcomes [56].